Clinical Disorder Treatment Market Share

On the basis of geographical analysis, the global clinical disorder treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in the Asia Pacific industry is expected to hold largest revenue share by 2036, ascribed to growing incidences of substance abuse among teenagers and adults, especially in India and China, and increasing prevalence of clinical disorders in the region.  In 2019, approximately 30 million people in South Asia admitted to using cannabis. Along with this, 22 million people consumed opioids in the region that year. Moreover, the market in North America is projected to acquire the largest share during the forecast period ascribing to the rising awareness levels about the symptoms of clinical disorders, and high healthcare spending in the region. In addition, strong presence of prominent market players is also expected to propel the clinical disorder treatment market growth in the region in the coming years.